Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Lepu Biopharma Co., Ltd. has entered into a CDMO Services Framework Agreement with Lepu Medical, aiming to provide technical services and equipment for GLP-1 and related products. As a connected transaction, it requires approval from independent shareholders and is subject to specific reporting and review requirements. An Extraordinary General Meeting will be held to consider and approve this agreement.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue